Cresset Asset Management, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Cresset Asset Management, LLC

  • $25.6 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $19.2 Million - $21.9 Million
-24,800 Reduced 90.18%
2,700 $2.37 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $154 Million - $188 Million
-222,500 Reduced 89.0%
27,500 $22.6 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $175 Million - $208 Million
250,000 New
250,000 $180 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email